Skip to content

Product
Clients
Experts
Company
Contact Us

Request a Trial

Open mobile menuClose mobile menu

Hybrid Group Meeting: (ASCO) American Society of Clinical Oncology 2026

All Group Meetings

Join Us At ASCO 2026

May 30 to June 1, Guidepoint Insights will be hosting a series of group meetings featuring KOLs who will dive deeper into ASCO 2026 updates.

"*" indicates required fields

URL

This field is for validation purposes and should be left unchanged.

Register for ASCO 2026 Expert Calls*

First Last

Phone*

Email*

Company*

CAPTCHA

Saturday, May 30

call-1

9:00 AM CT (10:00 AM ET) - Marc Braunstein | Multiple Myeloma | ET, MF, SM | Attending Physician in Hematology, NYU Winthrop Hospital

call-2

9:00 AM CT (10:00 AM ET) - Sanjay Aneja | Prostate | Director of Genitourinary Oncology, Griffin Hospital Inc.

call-4

10:00 AM CT (11:00 AM ET) - Gary Steinberg | Bladder Cancer | Professor of Urology, Rush University Medical Center

call-39

10:00 AM CT (11:00 AM ET) - Jason Henry | Early Clinical | Associate Director of Drug Development, Sarah Cannon Research Institute LLC

call-5

11:00 AM CT (12:00 PM ET) - Benjamin Besse | Lung | Professor, University of Paris-Saclay

call-6

11:00 AM CT (12:00 PM ET) - Ravi Vij | Multiple Myeloma | Professor of Medicine, Washington University in St. Louis

call-7

12:00 PM CT (1:00 PM ET) - Thomas Marron | Lung | Associate Director for Translational Research, Tisch Comprehensive Cancer Center, Mount Sinai Health System Inc.

call-8

12:00 PM CT (1:00 PM ET) - Paul DiSilvestro | Ovarian/GYN | Professor of Obstetrics and Gynecology at Brown University

call-9

1:00 PM CT (2:00 PM ET) - Robert Dreicer | Prostate Cancer | Director of Solid Tumor Oncology Within the Division of Hematology/Oncology and Professor of Medicine and Urology, University of Virginia School of Medicine

call-10

1:00 PM CT (2:00 PM ET) - Kamel Abou Hussein | Breast Cancer | Director of Breast Cancer Clinical Trials MD Anderson at Cooper, MD Anderson Cancer Center At Cooper

call-11

2:00 PM CT (3:00 PM ET) - Michael Morse | PDAC/CRC | Medical Oncologist at Duke University Health System Inc.

call-12

2:00 PM CT (3:00 PM ET) - Ashwin Kishtagari | MPN (MF, PV, ET), AML/MDS | Assistant Professor of Medicine at Vanderbilt University Medical Center

call-13

3:00 PM CT (4:00 PM ET) - Benjamin Herzberg | Early Clinical/Lung Cancer | Medical Oncologist and Assistant Professor of Medicine, Columbia University Medical Center

call-14

3:00 PM CT (4:00 PM ET) - Cesar Perez | Head and Neck Cancer | Director of Drug Development at Florida Cancer Specialists & Research Institute LLC

call-15

4:00 PM CT (5:00 PM ET) - Eric Christenson | PDAC/CRC | Assistant Professor of Oncology, Johns Hopkins University

call-16

4:00 PM CT (5:00 PM ET) - Siamak Daneshmand | Bladder Cancer | Associate Professor of Urology (Clinical Scholar); Director of Clinical Research, University of Southern California

Sunday, May 31

call-3

8:15 AM CT (9:15 AM ET) - Komal Jhaveri | Breast Cancer | Clinical Director of the Early Drug Development, Memorial Sloan Kettering Cancer Center

call-17

9:00 AM CT (10:00 AM ET) - Rodabe Amaria | Melanoma: Emerging IO and targeted therapies | Associate Professor, Department of Melanoma Oncology, The University of Texas M. D. Anderson Cancer Center

call-18

9:00 AM CT (10:00 AM ET) - Timothy Yap | Early Clinical | Head of Clinical Development in the Therapeutics Discovery Division, The University of Texas M. D. Anderson Cancer Center

call-20

10:00 AM CT (11:00 AM ET) - Patrick Forde | Lung Cancer | Prendergast Professor and Chair of Immuno-Oncology, Trinity College Dublin, The University of Dublin

call-19

10:00 AM CT (11:00 AM ET) - Benjamin Gartrell | Prostate Cancer | Associate Professor of Oncology in Medical Oncology, Associate Professor of Medicine in Oncology and Hematology, and Associate Professor of Urology, Albert Einstein College of Medicine

call-21

11:00 AM CT (12:00 PM ET) - Premal Thaker | Ovarian/GYN | Associate Professor in Gynecologic Oncology and Director of Gynecological Oncology Clinical Research, Washington University, St. Louis

call-22

11:00 AM CT (12:00 PM ET) - Giancarlo Moscol | Breast Cancer | Associate Professor of Breast Medical Oncology in Cancer Medicine at The University of Texas M. D. Anderson Cancer Center

call-23

12:00 PM CT (1:00 PM ET) - Jerome Fayette | Head and Neck Cancer | Medical Oncologist, Centre Léon Bérard

call-24

12:00 PM CT (1:00 PM ET) - Elias Jabbour | AML/MDS, CML, ALL | Associate Professor, The University of Texas M. D. Anderson Cancer Center

call-25

1:00 PM CT (2:00 PM ET) - David Camidge | Lung Cancer | Professor of Medical Oncology and the Director of Thoracic Oncology and the Thoracic Oncology Clinical Research Program, The University of Colorado

call-26

1:00 PM CT (2:00 PM ET) - Seth Wander | Breast Cancer | Clinical Assistant in Medicine / Medical Oncologist at Massachusetts General Hospital, Harvard Medical School

call-27

2:00 PM CT (3:00 PM ET) - Aarti Bhatia | Head and Neck Cancer | Clinical Research Team Leader for the Head and Neck Cancers Program and an Associate Professor of Medical Oncology, Yale University School Of Medicine

call-28

2:00 PM CT (3:00 PM ET) - Scott Tagawa | Prostate Cancer | Attending Physician, The New York and Presbyterian Hospital Inc.

call-29

3:00 PM CT (4:00 PM ET) - Daniel Olson | Melanoma: Emerging IO and targeted therapies | Assistant Professor of Medicine, The University of Chicago

call-30

3:00 PM CT (4:00 PM ET) - Joshua Brody | Lymphomas | Associate Professor & Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai

call-31

4:00 PM CT (5:00 PM ET) - Michael Pishvaian | PDAC/CRC | Director of the Gastrointestinal, Developmental Therapeutics & Clinical Research Programs, Johns Hopkins School of Medicine

call-32

4:00 PM CT (5:00 PM ET) - Rajwanth Veluswamy | Lung Cancer | Associate Professor of Medicine, NYU Langone Hospitals

Monday, June 1

call-33

8:00 AM CT (9:00 AM ET) - Jordi Rodón | PRMT5 | Associate Medical Director at the Institute for Personalized Cancer Therapy and the Clinical Co-Director of the Precision Oncology Decision Support Group in the Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center

call-34

8:00 AM CT (9:00 AM ET) - Peter Enzinger | PDAC/CRC | Medical Oncologist and Director of the Center for Esophageal and Gastric Cancer, Harvard Medical School

call-35

9:00 AM CT (10:00 AM ET) - Christos Vaklavas | Breast Cancer | Professor of Medicine in the Division of Oncology and Physician Lead in Breast Cancer, The University of Utah

call-36

9:00 AM CT (10:00 AM ET) - Roy Herbst | Lung Cancer | Chief of Medical Oncology, Yale University School Of Medicine

call-37

10:00 AM CT (11:00 AM ET) - Jason Luke | Melanoma: Emerging IO and targeted therapies | CMO, Strand Therapeutics Inc

call-38

10:00 AM CT (11:00 AM ET) - David Hong | PDAC/KRAS | Deputy Director of the Department of Investigational Cancer Therapeutics in the Division of Cancer Medicine, University of Texas M. D. Anderson Cancer Center

call-40

11:00 AM CT (12:00 PM ET) - Jared Weiss | Lung Cancer | Professor of Medicine and Section Chief of Thoracic and Head & Neck Oncology at University of North Carolina, Chapel Hill School of Medicine

call-41

12:00 PM CT (1:00 PM ET) - Marcus Butler | Melanoma | Medical Oncologist, Princess Margaret Cancer Centre

call-42

12:00 PM CT (1:00 PM ET) - Ignacio Garrido-Laguna | PDAC: KRAS | Chair of Experimental Therapeutics, H. Lee Moffitt Cancer Center & Research Institute Inc.

call-43

1:00 PM CT (2:00 PM ET) - Ryan Corcoran | PDAC/CRC | GI Oncologist and Director of the Tucker Gosnell Center for Gastrointestinal Cancers, Alterome Therapeutics Inc.

call-44

1:00 PM CT (2:00 PM ET) - John Mascarenhas | MPN (MF, PV, ET), AML | Professor of Medicine at Icahn School of Medicine at Mount Sinai

call-45

2:00 PM CT (3:00 PM ET) - Namrata Vijayvergia | PDAC/CRC | Section Chief in the Division of Gastrointestinal Oncology, Fox Chase Cancer Center Medical Group Inc.

call-46

2:00 PM CT (3:00 PM ET) - Konstantin Dragnev | Lung Cancer | Interim Director, Dartmouth Cancer Center

call-47

3:00 PM CT (4:00 PM ET) - Nataliya Uboha | PDAC/CRC | Associate Professor of Medicine and the Faculty Leader of the Early-Phase Oncology Therapeutics Program, University of Wisconsin - Madison

call-48

3:00 PM CT (4:00 PM ET) - Praveen Vikas | Breast Cancer | Clinical Associate Professor, Medical Oncologist, University of Iowa Hospitals and Clinics

Δ

*ASCO Group Meetings will be 50 minutes long and available only to attendees. Group meetings are not recorded and transcripts will not be available following the event.

Contact Us

For more information, contact a Guidepoint representative at [email protected].

Guidepoint Headquarters

675 6th Avenue, Floor 2,
New York, NY 10010
212-375-2980

Request a Trial

Start Today

Explore Guidepoint360

Learn More

From Our BlogThe Opportunities in APAC Data Centers Being Driven by Battery Technology Advancements

Facebook Instagram LinkedIn

Expert Insights

Institutional Investors

Investment Banks

Professional Services

Data Transfer Policy

Advisor Terms & Conditions

Modern Slavery Statement

New York • Boston • Phoenix • San Francisco • Honolulu • Toronto • London • Athens • Dubai • Mumbai • Pune • Singapore • Hong Kong • Beijing • Shanghai • Seoul • Tokyo • Osaka • Sydney

© 2026 Guidepoint Global, LLC. All rights reserved. Guidepoint® and the marks relating to Guidepoint products and services are either trademarks or registered trademarks

Product
Clients
Experts
Company
- About
- Careers
- Resources
- FAQs
Contact Us